Quick Search

 

 


 

 

Result Summary for 114729

Result Summary
Protocol ID: 114729
Clinical Study ID: STF114729
Official Title: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers
Phase: phase 1
Study Indications or Diseases:
  • Acne Vulgaris
Generic Name: clindamycin phosphate/tretinoin
Trade/Product Name: Veltin
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.